Breaking News, Promotions & Moves

ProBio Appoints Key Leaders

Appoints new CEO, Senior Vice President of U.S. Business Development, and U.S. Site Head and Interim Head of U.S. Process Development.

Author Image

By: Charlie Sternberg

Associate Editor

ProBio, a global Contract Development and Manufacturing Organization (CDMO), has appointed Allen Guo as Chief Executive Officer (CEO), Whitney Winters as Senior Vice President of U.S. Business Development, and Michael Vreeland as the U.S. Site Head and Interim Head of U.S. Process Development, effective December 1, 2024.   Dr. Li Chen, the previous CEO of ProBio, will remain as a consultant to ensure a smooth transition and on-going progress.   These leadership changes align with ProBio&#821...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters